Semaglutide 1520% body weight loss Our preferred GLP-1 option (Wegovy / Ozempic) significant, sustained results
However, in patients with T1D, glucagon secretion is not suppressed by hyperglycemia
There is no official contraindication for Wegovy use in people with a history of non-diabetic hypoglycaemia, but careful monitoring is advisable
10.1016/j.expneurol.2020.113331 171 HashimH.AzminS.RazlanH.YahyaN
Retatrutide may turn it up, being the strongest
Reported public examples tied to reduced-price initiatives suggest injectable reduced-tier discussions around the low-to-mid hundreds per month and starter oral tiers around $149/month, but actual costs depend on eligibility, supply, and pharmacy choices